More than a genital psoriasis
- 16 November 2022
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (12), e15971
- https://doi.org/10.1111/dth.15971
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Exclusively genital psoriasis successfully treated with RisankizumabDermatologic Therapy, 2022
- Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital PsoriasisJournal of Clinical Medicine, 2022
- Risankizumab shows high efficacy and maintenance in improvement of response until week 52Dermatologic Therapy, 2022